![Jonathan Haug](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Jonathan R.
Haug is currently Chief Executive Officer at ARMO Biosciences, Inc. and DICE Therapeutics, Inc. He is President & Director at Ventyx Biosciences, Inc. starting in 2026, President & Director at Morphic Holding, Inc., President & Director at Adverum Biotechnologies, Inc. starting in 2025, President & Director at Scorpion Therapeutics, Inc., and President at Verve Therapeutics, Inc. starting in 2025.
Formerly, Mr. Haug was Chief Executive Officer at Prevail Therapeutics, Inc.
Aktive Positionen von Jonathan Haug
| Unternehmen | Position | Beginn |
|---|---|---|
| VERE THER | Präsident | 25.07.2025 |
| ADVERUM BIOTECHNOLOGIES, INC. | Präsident | 09.12.2025 |
| VENTYX BIOSCIENCES, INC. | Präsident | 04.03.2026 |
| MORC HOLD | Präsident | - |
| ARMO BIOSCIENCES INC | Vorstandsvorsitzender | - |
| DICE THER | Vorstandsvorsitzender | - |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment | Präsident | - |
Ehemalige bekannte Positionen von Jonathan Haug
| Unternehmen | Position | Ende |
|---|---|---|
| PREVAIL THERAPEUTICS INC. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment | Health Technology |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
